Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
10 hedge funds and large institutions have $250K invested in Apollo Endosurgery, Inc. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
125% more capital invested
Capital invested by funds: $111K → $250K (+$139K)
9% less funds holding
Funds holding: 11 → 10 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$42.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$93 |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$13 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 2 |
JP Morgan Chase
New York
|
-$2K |
APEN Hedge Fund Activity: Q3 2016 in Review
10 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2016, worth a combined $250K — up 125% from $111K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of APEN and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $42.4K. The largest seller was UBS Group, exiting entirely with an estimated $6K sold.
- 10 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2016, down from 11 in Q2 2016.
- Funds reported $250K of Apollo Endosurgery, Inc. stock for Q3 2016, up 125% quarter-over-quarter.
- 2 funds opened new Apollo Endosurgery, Inc. positions in Q3 2016 and 3 closed out, a net change of -1 holder.
- The largest Apollo Endosurgery, Inc. buyer in Q3 2016 was Renaissance Technologies, an estimated $42.4K added.
- The largest Apollo Endosurgery, Inc. seller in Q3 2016 was UBS Group, an estimated $6K sold.
Based on aggregated 13F filings for Q3 2016.